Phylogica Limited (PYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
32 Pages - GLDATA56206
$250.00

Summary

Phylogica Limited (Phylogica) is a biotechnology company that provides peptide drug discovery services to the pharmaceutical industry. The company’s products include libraries and peptides. Its Phylomer libraries are in variety of phage display and yeast-two-hybrid formats and in mammalian expression vectors for phenotypic screening, and Phylomer peptides are the biological therapeutics and derived from Phylomer libraries. Phylogica utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. The company discovers and patents peptide therapeutics (Phylomer peptides) which exhibit competitive therapeutic, manufacturing, and commercial advantages over proteins, monoclonal antibodies and most current therapeutic peptides. Phylomer peptides are used for the treatment of disease associated proteins and their interactions. Phylogica is headquartered in Mount Claremont, Australia.

Phylogica Limited (PYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Phylogica Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Phylogica Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Phylogica Limited, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Phylogica Enters Into Co-Marketing Agreement With Bio-Link For Anti-Inflammatory Phylomers 10
Phylogica Enters Into Joint Venture Agreement With University Of Cambridge 12
Phylogica Enters Into Discovery Collaboration With MedImmune 13
Licensing Agreements 14
Phylogica Enters into Licensing Agreement with PhoreMost 14
Phylogica Enters into Licensing Agreement with Genentech 15
Phylogica Expands Licensing Agreement With Janssen Biotech For Peptide Drug Conjugates 17
Phylogica Expands Licensing Agreement With Janssen Biotech For Peptide Drug Conjugates 18
Phylogica Enters Into Licensing Agreement With Janssen Biotech For Phylomer Technology 19
Phylogica Enters Into Collaboration And Licensing Agreement With Pfizer 20
Phylogica Enters Into Licensing Agreement With Isogenica 22
Equity Offering 23
Phylogica Raises USD6.7 Million in Rights Offering of Shares 23
Phylogica Completes Rights Offering Of Shares For US$3.3 Million 25
Phylogica Completes Private Placement Of Common Stock For US$2.2 Million 26
Phylogica Completes Private Placement Of US$5.3 Million 28
Phylogica Limited - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Phylogica Limited, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Phylogica Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Phylogica Limited, Deals By Therapy Area, 2010 to YTD 2016 8
Phylogica Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Phylogica Enters Into Co-Marketing Agreement With Bio-Link For Anti-Inflammatory Phylomers 10
Phylogica Enters Into Joint Venture Agreement With University Of Cambridge 12
Phylogica Enters Into Discovery Collaboration With MedImmune 13
Phylogica Enters into Licensing Agreement with PhoreMost 14
Phylogica Enters into Licensing Agreement with Genentech 15
Phylogica Expands Licensing Agreement With Janssen Biotech For Peptide Drug Conjugates 17
Phylogica Expands Licensing Agreement With Janssen Biotech For Peptide Drug Conjugates 18
Phylogica Enters Into Licensing Agreement With Janssen Biotech For Phylomer Technology 19
Phylogica Enters Into Collaboration And Licensing Agreement With Pfizer 20
Phylogica Enters Into Licensing Agreement With Isogenica 22
Phylogica Raises USD6.7 Million in Rights Offering of Shares 23
Phylogica Completes Rights Offering Of Shares For US$3.3 Million 25
Phylogica Completes Private Placement Of Common Stock For US$2.2 Million 26
Phylogica Completes Private Placement Of US$5.3 Million 28
Phylogica Limited, Key Competitors 29
Phylogica Limited, Key Employees 30
Phylogica Limited, Other Locations 31
Phylogica Limited, Subsidiaries 31

List of Figures
Phylogica Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Phylogica Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Phylogica Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838